In a Medscape Medical News article about recognizing when a patient has inflammatory back pain and clinical features of spondyloarthritis, Atul Deodhar, M.D., says, "Axial spondyloarthritis is one disease, and whether it is radiographic on non-radiographic makes zero difference in the management of the patient."

Two OHSU oncology nurses share their concerns about building safety.

The Advocate covers a threatening phone call to Richmond Clinic, and readers respond to The Oregonian's coverage of the incident in letters to the editor, including from a breast cancer survivor who praises Richmond Clinic for creating a safe environment.

A "Research Training Spotlight" article by the National Institute on Aging highlights the career of Ana Quiñones, Ph.D., who studies how people of different races and ethnicities develop chronic illnesses as they get older.

National and local news outlets report on a threating phone call, which prompted OHSU’s Richmond Clinic to evacuate on Thursday, August 3. Additional security measures have been put in place at Richmond and OHSU is offering resources and support options through the well-being program.

At a U.S. Rep. Suzanne Bonamici-hosted roundtable discussion about the dangers of fentanyl and counterfeit pills, Todd Korthuis, M.D., says, “The first thing to understand about fentanyl is that it really is worse and different than other drugs. It's 50 times more potent than heroin. It's cheaper to purchase on the street. And due to a variety of characteristics, the drug is much worse than other drugs that we've been seeing in the past.”

A physician assistant in the OHSU Immediate Care Clinics is indicted for sex abuse by a Washington County Grand Jury, following an investigation into allegations of inappropriate behavior during a medical exam at the Beaverton clinic. The PA was placed on leave and his access to OHSU patient information and facilities has been terminated.

OHSU seeks proposals from Klamath Falls-area residents about local public and rural health projects in which OHSU Campus for Rural Health learners could engage.

The ASCO Post covers a study led by Chris Ryan, M.D., finding adjuvant everolimus was not associated with a significant improvement in event-free survival vs placebo in patients at high risk of disease recurrence following surgery for renal cell carcinoma.

An OHSU study from 2016 that found “false-positive results are common and are higher for annual screening, younger women, and women with dense breasts” is mentioned in an article on breast cancer overdiagnosis.